Stocks and Investing Stocks and Investing
Thu, February 13, 2020

Amit Hazan Initiated (ABT) at Hold and Held Target at $96 on, Feb 13th, 2020


Published on 2024-10-26 21:51:01 - WOPRAI, Amit Hazan
  Print publication without navigation


Amit Hazan of Goldman Sachs, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $96 on, Feb 13th, 2020.

Amit has made no other calls on ABT in the last 4 months.



There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 3 agree with Amit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Marie Thibault of "BTIG" Initiated at Hold on, Thursday, February 6th, 2020
  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $102 on, Thursday, January 23rd, 2020
  • Christopher Pasquale of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 2nd, 2020


These are the ratings of the 6 analyists that currently disagree with Amit


  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Thursday, January 23rd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $104 on, Thursday, January 23rd, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $99 on, Thursday, January 23rd, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $103 on, Thursday, January 23rd, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $101 on, Tuesday, December 17th, 2019
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, October 17th, 2019
Contributing Sources